18
Participants
Start Date
May 1, 2023
Primary Completion Date
November 30, 2024
Study Completion Date
December 30, 2027
FT-003
Administered via intraocular injection.
Lead Sponsor
The First Affiliated Hospital of Soochow University
OTHER
Tianjin Medical University Eye Hospital
OTHER
Peking Union Medical College Hospital
OTHER
The First Affiliated Hospital of Zhengzhou University
OTHER
Frontera Therapeutics
INDUSTRY